Dhruva Lab

Research focus

NIH R01 · 2024

Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study

PROJECT SUMMARY BACKGROUND: There are currently more than 4 million breast cancer survivors in the U.S., and an additional 287,000 will be diagnosed in 2022. Although the growing number of breast cancer survivors reflect advances in detection and treatment, the transition to post-treatment survivorship remains challenging. Patients are left with sequelae due to their cancer diagnosis and treatment resulting in impairments in quality of life (QOL) and an ongoing burden from cancer. Few safe and effective approaches currently exist to address this gap in care. We have developed and piloted integrative medicine interventions for cancer survivors including a personalized and patient-centered…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.